drugset / Trial / NCT03982862
Botulinum Toxins Intralesional Injection for Scar Pain
RandomizedCrossoverSingle-blindTreatment
Summary
Botulinum toxins has been approved by the FDA to treat chronic migraine. Botox had been shown to inhibiting the release of inflammatory mediators and peripheral neurotransmitters from sensory nerve to treat neuropathic pain. In the clinical practice, botox indeed effect in scar pain. However, investigators need well controlled study to prove this finding and assess the improvement of scar appearance.
Timeline
- Start
- 2018-07-30
- Primary completion
- 2019-06-30
- Completion
- 2019-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 4 iu | Other |
| Subject | Triamcinolone | Other / unclassified | 4 mg | Other |
| Background | Lidocaine | Other / unclassified | 0.1 ml | Other |